Stagwell (STGW) 10-K2023 FY Annual report

Filed: 11 Mar 24, 4:31pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: actor, aforementioned, AlpInvest, app, bad, blended, blending, cohort, collapse, compensatory, ConcentricLife, cultivate, delegated, Denmark, Dimension, discriminatory, divested, divestiture, dozen, elevated, endpoint, Epiphany, Es, ESPP, ethical, fabricated, fifteen, forthcoming, FTC, Gaza, grapple, handle, Instacart, instant, intensive, investigate, investigation, Ireland, Israel, Left, LFL, mid, misclassification, monetize, mutual, overstated, overstatement, pausing, predecessor, prioritize, Quest, reclassed, saudi, Sidekick, stemming, Storyline, Strait, stronger, Switzerland, thousand, Tinsel, tool, transparency, triage, understatement, unexpected, unintended, writer

Removed: actuarial, aggregating, Aid, applying, closely, comparing, Concentric, conform, coupled, creating, dated, decreasing, deduction, exclusion, exploring, expressed, importance, incidental, length, nominee, occurrence, outsized, Overview, payroll, refundable, repay, revolver, sample, sensitivity, Sloane, unqualified, Vincenzo, Vitro

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated STGW transcripts

STGW similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Form S-8’s (Nos. 333-226895, 333-212261, 333-176059, 333-265600, and 333-270335) and Form S-3 (No. 333-260202) of our report dated March 6, 2023 (March 11, 2024 as to the effects of the restatement discussed in Note 21), relating to the financial statements and the related notes and schedules listed in the Index at Item 15 of Stagwell Inc. (the “Company”) and our report dated March 6, 2023 relating to the effectiveness of the Company’s internal control over financial reporting (which report expresses an adverse opinion on the effectiveness of the Company's internal control over financial reporting because of material weaknesses), appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.

/s/ Deloitte & Touche LLP

New York, NY

March 11, 2024